interventions [hlca]
Cancer Patient [podg]
Receive [qlco]
Anthracyclines [antb, orch]
Anthracyclines [antb, orch]
effective [qlco]
chemotherapeutic agent [orch, phsu]
treatment [ftcn]
Numerous [qnco]
malignancies [neop]
Limited [ftcn]
Dose-dependent [qnco]
Cardiotoxicity [inpo]
Effort [orgf]
PREVENT [phsu]
Cardiotoxicity [inpo]
Cardioprotective Agents [phsu]
Study [mnob]
objectives [inpr]
Objective [inpr]
Efficacy [qlco]
Cardioprotective Agents [phsu]
PREVENT [phsu]
Heart [bpoc]
Damage [inpo]
Cancer Patient [podg]
treated [topp]
Anthracyclines [antb, orch]
search [inpr]
strategy [menp]
Searched [acty]
Central [spco]
Controlled [ftcn]
Trial [resa]
Library [mnob, orgt]
Issue [fndg]
MEDLINE [inpr]
Databases [inpr]
Addition [ftcn]
Reference [idcn]
List [cnce]
conference proceedings [inpr]
International [idcn]
society [orgt]
Pediatric Oncology [bmod]
American Society of Clinical Oncology [pros]
Meeting [hlca]
ONGOING [idcn]
Trial [resa]
Registers [inpr]
Selection Criteria [qlco]
Controlled [ftcn]
Trial [resa]
Cardioprotective Agent [phsu]
Compared [acty]
Additional Therapy [fndg]
placebo [topp]
Cancer Patient [podg]
Children [aggp]
Adults [aggp]
Receive [qlco]
Anthracyclines [antb, orch]
Data Collection [resa]
Authors [prog]
Performed [ftcn]
Study [mnob]
Bias [idcn]
Assessment [hlca]
Data Extraction [resa]
Including [ftcn]
adverse effects [ftcn]
Main [qlco]
Identified [qlco]
Controlled [ftcn]
Trial [resa]
Eight [qnco]
Cardioprotective Agents [phsu]
Acetyl cysteine [aapp, phsu]
Phenethylamines [orch, phsu]
coenzyme Q10 [bacs, orch, phsu]
Combination [qlco]
Vitamin E [lipd, phsu, vita]
N-Acetylcysteine [aapp, phsu]
L-Carnitine [aapp, phsu]
carvedilol [orch, phsu]
Amifostine [opco, phsu]
Dexrazoxane [orch, phsu]
Adults [aggp]
Advanced Cancer [neop]
Breast [bpoc]
methodology [inpr]
limitations [ftcn]
Seven [qnco]
Agent [chvf]
Study [mnob]
Pooling [ftcn]
included [ftcn]
Dexrazoxane [orch, phsu]
Patients [podg]
Meta-Analysis [inpr]
Dexrazoxane [orch, phsu]
statistically significant [qnco]
Benefit [qnco]
Dexrazoxane [orch, phsu]
occurrence [ftcn]
Heart failure [dsyn]
Risk Ratio [qnco]
CI-20 [gngm]
Response Rate [tmco]
Survival [acty]
Dexrazoxane [orch, phsu]
Control Groups [grup]
adverse effects [ftcn]
Ambiguous [orga]
occurrence [ftcn]
secondary malignancies [neop]
Identified [qlco]
Authors [prog]
Conclusions [idcn]
Definitive [tmco]
Conclusions [idcn]
Make [ftcn]
Efficacy [qlco]
Cardioprotective Agents [phsu]
Pooling [ftcn]
Dexrazoxane [orch, phsu]
PREVENT [phsu]
Heart [bpoc]
Damage [inpo]
Response Rate [tmco]
Survival [acty]
Dexrazoxane [orch, phsu]
Control Groups [grup]
Identified [qlco]
Available [ftcn]
Reach [orgf]
Definite [qlco]
Conclusions [idcn]
adverse effects [ftcn]
conclude [bodm, orch]
Cardiac [bpoc]
Damage [inpo]
Expected [idcn]
justify [ftcn]
Dexrazoxane [orch, phsu]
Patients [podg]
treated [topp]
Anthracyclines [antb, orch]
clinicians [prog]
Dexrazoxane [orch, phsu]
adverse effects [ftcn]
